{"id":"W2088605318","doi":"10.1007/s00280-007-0579-4","title":"Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety","year":2007,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"Pfizer","keywords":"Pharmacokinetics; Dosing; Medicine; Adverse effect; Toxicity; Internal medicine; Tyrosine-kinase inhibitor; Incidence (geometry); Pharmacology; Clinical trial; Gastroenterology; Oncology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000576673,0.0004751962,0.001339788,0.0003678488,0.0002810752,0.0006493946,0.000280835,0.0004699866,0.0009594539],"category_scores_gemma":[0.002694145,0.0004238847,0.0005278871,0.0005138686,0.0002907019,0.0007075054,0.0001565687,0.001750789,0.0002650048],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008203549,"about_ca_system_score_gemma":0.0008232371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001510162,"about_ca_topic_score_gemma":0.002005253,"domain_scores_codex":[0.9996331,0.0001682482,0.00002297518,0.00005480368,0.00006777491,0.00005308484],"domain_scores_gemma":[0.9990189,0.0003315704,0.0002662168,0.00005912964,0.00006205261,0.000262218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4233728,0.006115174,0.1949103,0.0003226754,0.002069521,0.001453212,0.0005454633,0.01307221,0.1333952,0.0005599977,0.003601016,0.2205825],"study_design_scores_gemma":[0.02662511,0.1654842,0.7290282,0.00005387155,0.002107232,0.005074981,0.0003104203,0.02269023,0.04045871,0.0006098747,0.007378636,0.0001784259],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968125,0.001377149,0.0004858131,0.0001775494,0.0000214626,0.00003943505,0.0002690156,0.00005918361,0.0007578551],"genre_scores_gemma":[0.9984617,0.0004020992,0.0002746006,0.00009659736,0.00003823366,0.00002203724,0.0002953698,0.0000182494,0.0003911503],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001510162,"threshold_uncertainty_score":0.00595212,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01812089181977916,"score_gpt":0.380221315198652,"score_spread":0.3621004233788728,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}